臨床前影像市場規模、佔有率和成長分析（按組件、模式、應用和地區分類）—2026-2033年產業預測

全球臨床前影像市場規模預計在 2024 年達到 37.7 億美元，從 2025 年的 39.5 億美元成長到 2033 年的 57.5 億美元，在預測期（2026-2033 年）內複合年成長率為 4.8%。

全球臨床前影像市場正蓬勃發展，其主要驅動力是藥物研發、分子生物學和轉化醫學領域對先進研究工具日益成長的需求。該領域對於評估新型候選藥物的療效和安全性、了解疾病進展以及推進個人化醫療至關重要。此外，慢性病、癌症和神經系統疾病發病率的上升也推動了該行業的成長，因為這些疾病需要精準、非侵入性的影像方法來研究動物模型中的疾病機制。近年來，高解析度磁振造影（MRI）、正子斷層掃描（PET）、電腦斷層掃描（CT）和多模態影像系統等技術的創新，提高了研究人員即時觀察生物過程的能力。此外，人工智慧和機器學習在影像分析中的應用，也使得影像解讀更加精準。該領域持續成長的資金籌措和合作項目，凸顯了臨床前研究中對可擴展成像解決方案日益成長的需求。

全球臨床前影像市場促進因素

慢性病、癌症和神經系統疾病的日益增多，推動了人們對精準、非侵入性且創新的臨床前成像技術的興趣。製藥和生物製藥公司正利用這些先進的影像工具來評估藥物療效、追蹤疾病進展並最佳化治療策略。此外，對高效、全面的藥物研發流程的持續需求，也促使人們增加對高解析度和多模態成像技術的投資。這些因素共同作用，顯著影響全球臨床前造影市場的格局，相關人員都在尋求提升研發能力和加速有效治療方法開發的解決方案。

限制全球臨床前影像市場的因素

全球臨床前影像市場面臨諸多限制因素，主要源自於購置和維護先進成像系統所需的高成本。對於開發中國家的小規模實驗室、Start-Ups公司和研究機構而言，這筆經濟負擔尤其沉重。高解析度磁振造影（MRI）、正子斷層掃描/電腦斷層掃描（PET/CT）和混合成像系統等高階技術不僅需要大量的初始投資，還需要持續投入資金用於系統校準、軟體更新、維護以及耗材等。此外，還需要聘請或培訓專業人員來有效操作這些複雜的系統，這進一步增加了營運成本，也為許多機構進入該市場設定了進入門檻。

全球臨床前影像市場趨勢

全球臨床前影像市場正經歷顯著的發展趨勢，而人工智慧 (AI) 和機器學習 (ML) 技術的應用日益廣泛是推動這一趨勢的關鍵因素。這些技術的融合透過自動化影像分析、組織分割、生物標記識別和預測建模等方式，顯著提升了成像流程，簡化了工作流程，減少了人工操作。隨著這些先進工具不斷提高成像精度並簡化複雜成像數據的解讀，研究人員能夠更有效率地獲取更有價值的資訊。 AI 和 ML 對影像能力的持續提升，不僅推動了臨床前研究的創新，也加速了各生物醫學領域新型治療方案的研發。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球臨床前影像市場規模（按組件分類）及複合年成長率（2026-2033 年）

• 硬體系統
• 軟體和服務

全球臨床前影像市場規模（以影像方式分類）及複合年成長率（2026-2033 年）

• 磁振造影（MRI）
• 正子斷層掃描（PET）
• 電腦斷層掃描（CT）
• 光學成像
• 超音波影像
• 單光子發射電腦斷層掃描（SPECT）
• 多模態成像

全球臨床前影像市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 藥物發現與開發
• 疾病監測
• 轉換醫學
• 毒理學研究

全球臨床前影像市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Bruker Corporation（USA）
• Revvity, Inc.（USA）
• FUJIFILM VisualSonics Inc.（Canada）
• Mediso Medical Imaging Systems Ltd.（Hungary）
• MR Solutions（UK）
• Aspect Imaging Limited（USA）
• TriFoil Imaging（USA）
• MILabs BV（Netherlands）
• Siemens Healthineers AG（Germany）
• General Electric（GE）HealthCare Technologies Inc.（USA）
• Cubresa Inc.（Canada）
• Berthold Technologies GmbH & Co. KG（Germany）
• Miltenyi Biotec GmbH（Germany）
• Li-Cor Biosciences（USA）
• Sofie（USA）
• Advanced Molecular Vision（UK）
• Vieworks Co., Ltd.（South Korea）
• Kub Technologies（USA）
• Medikors Inc.（South Korea）
• SCANCO Medical AG（Switzerland）

結論與建議

Global Preclinical Imaging Market size was valued at USD 3.77 Billion in 2024 and is poised to grow from USD 3.95 Billion in 2025 to USD 5.75 Billion by 2033, growing at a CAGR of 4.8% during the forecast period (2026-2033).

The global preclinical imaging market is on an upward trajectory, driven by a rising demand for sophisticated research tools in drug discovery, molecular biology, and translational medicine. This sector is crucial for assessing the efficacy and safety of new drug candidates, comprehending disease progression, and advancing personalized therapies. The industry growth is further fueled by the rising incidence of chronic, cancerous, and neurological diseases necessitating precise, non-invasive imaging methods for studying disease mechanisms in animal models. Recent technological innovations, including high-resolution MRI, PET, CT, and multimodal imaging systems, enhance researchers' capabilities to visualize biological processes in real-time. Additionally, the integration of AI and machine learning in imaging analysis is creating more accurate interpretations as funding and collaborations within the sector continue to flourish, highlighting the demand for scalable imaging solutions in preclinical studies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Preclinical Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Preclinical Imaging Market Segments Analysis

Global Preclinical Imaging Market is segmented by Component, Modality, Application and region. Based on Component, the market is segmented into Hardware Systems and Software & Services. Based on Modality, the market is segmented into Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT), Optical Imaging, Ultrasound Imaging, Single Photon Emission Computed Tomography (SPECT) and Multimodal Imaging. Based on Application, the market is segmented into Drug Discovery & Development, Disease Research, Translational Medicine and Toxicology Studies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Preclinical Imaging Market

The rise in chronic diseases, cancer, and neurological disorders is driving heightened interest in innovative preclinical imaging techniques that offer precision and non-invasiveness. Both pharmaceutical and biopharmaceutical companies are leveraging these advanced imaging tools to assess drug effectiveness, track disease progression, and refine treatment strategies. Additionally, the ongoing demand for efficient and thorough drug discovery processes is propelling investments into high-resolution and multimodal imaging technologies. This confluence of factors is significantly shaping the landscape of the global preclinical imaging market, as stakeholders seek solutions that enhance research capabilities and accelerate the development of effective therapeutics.

Restraints in the Global Preclinical Imaging Market

The Global Preclinical Imaging market faces significant restraints primarily due to the substantial costs involved in acquiring and maintaining advanced imaging systems. This financial burden can be particularly challenging for smaller laboratories, startups, and research institutions in developing countries. High-end technologies like high-resolution MRI, PET/CT, and hybrid imaging systems demand not only a considerable initial investment but also continuous expenses related to system calibration, software updates, maintenance, and necessary consumables. Additionally, the need to hire or train specialized personnel to effectively operate these complex systems further escalates operational expenditures, posing a barrier to entry for many organizations in the market.

Market Trends of the Global Preclinical Imaging Market

The Global Preclinical Imaging market is witnessing a significant trend driven by the rising adoption of artificial intelligence (AI) and machine learning (ML) technologies. This integration enhances imaging processes through automated image analysis, tissue segmentation, biomarker identification, and predictive modeling, streamlining workflows and reducing manual workloads. As these advanced tools improve accuracy and facilitate the interpretation of complex imaging data, researchers are empowered to derive more meaningful insights efficiently. The ongoing enhancement of imaging capabilities through AI and ML not only fosters innovation in preclinical research but also accelerates the development of novel therapeutic solutions across various biomedical fields.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Preclinical Imaging Market Size by Component & CAGR (2026-2033)

• Market Overview
• Hardware Systems
• Software & Services

Global Preclinical Imaging Market Size by Modality & CAGR (2026-2033)

• Market Overview
• Magnetic Resonance Imaging (MRI)
• Positron Emission Tomography (PET)
• Computed Tomography (CT)
• Optical Imaging
• Ultrasound Imaging
• Single Photon Emission Computed Tomography (SPECT)
• Multimodal Imaging

Global Preclinical Imaging Market Size by Application & CAGR (2026-2033)

• Market Overview
• Drug Discovery & Development
• Disease Research
• Translational Medicine
• Toxicology Studies

Global Preclinical Imaging Market Size & CAGR (2026-2033)

• North America (Component, Modality, Application)
  • US
  • Canada
• Europe (Component, Modality, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Modality, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Modality, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Modality, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM VisualSonics Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediso Medical Imaging Systems Ltd. (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MR Solutions (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aspect Imaging Limited (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TriFoil Imaging (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MILabs B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric (GE) HealthCare Technologies Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cubresa Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berthold Technologies GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Li-Cor Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sofie (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Molecular Vision (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vieworks Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kub Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medikors Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SCANCO Medical AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations